Scarica l'app Stockscreener
156.13
4.79%
7.14
Dopo l'orario di chiusura:
156.13
Precedente Chiudi:
$148.99
Aprire:
$152.88
Volume 24 ore:
5.40M
Relative Volume:
2.94
Capitalizzazione di mercato:
$26.35B
Reddito:
$15.50B
Utile/perdita netta:
$1.33B
Rapporto P/E:
21.27
EPS:
7.34
Flusso di cassa netto:
$2.16B
1 W Prestazione:
+2.51%
1M Prestazione:
+7.27%
6M Prestazione:
-26.90%
1 anno Prestazione:
-33.30%
Intervallo 1D:
$151.50
$156.53
Intervallo di 1 settimana:
$143.65
$156.53
Portata 52W:
$135.97
$252.88
Iqvia Holdings Inc Stock (IQV) Company Profile
Nome
Iqvia Holdings Inc
Settore
Industria
Telefono
919-998-2000
Indirizzo
2400 ELLIS ROAD, DURHAM, NC
Confronta IQV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
156.13 | 26.35B | 15.50B | 1.33B | 2.16B | 7.34 |
|
TMO
Thermo Fisher Scientific Inc
|
432.59 | 159.40B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
200.83 | 141.27B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
509.53 | 38.21B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
115.55 | 30.90B | 6.53B | 1.26B | 1.31B | 4.35 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-25 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-04-10 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-02-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-12-20 | Iniziato | Stephens | Overweight |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-09-04 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-07-24 | Downgrade | Jefferies | Buy → Hold |
| 2024-06-06 | Iniziato | Goldman | Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-15 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-02-13 | Iniziato | BTIG Research | Buy |
| 2023-11-02 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-03-17 | Iniziato | Truist | Buy |
| 2022-12-06 | Iniziato | Cowen | Outperform |
| 2022-11-17 | Downgrade | Citigroup | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-15 | Iniziato | SVB Leerink | Outperform |
| 2022-05-24 | Iniziato | Guggenheim | Buy |
| 2022-04-29 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-04-16 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2020-07-07 | Iniziato | Stephens | Equal-Weight |
| 2020-03-02 | Iniziato | Deutsche Bank | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-12-13 | Aggiornamento | CFRA | Sell → Hold |
| 2019-11-14 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | Aggiornamento | Mizuho | Neutral → Buy |
| 2019-05-28 | Iniziato | SVB Leerink | Outperform |
| 2019-01-18 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-10-09 | Iniziato | UBS | Buy |
| 2018-10-02 | Reiterato | Robert W. Baird | Outperform |
| 2018-07-25 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | Reiterato | Stifel | Buy |
| 2018-07-03 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-03-07 | Aggiornamento | SunTrust | Hold → Buy |
| 2018-01-19 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Iqvia Holdings Inc Borsa (IQV) Ultime notizie
IQVIA: Q1 Earnings Support Steady Optimism (NYSE:IQV) - Seeking Alpha
IQVIA raises 2025 revenue guidance amid strong TAS growth and expanded AI deployment - MSN
Morgan Stanley Adjusts Price Target on IQVIA Holdings to $185 From $250, Maintains Overweight Rating - marketscreener.com
IQVIA Holdings Inc. (NYSE:IQV) Q1 2025 Earnings Call Transcript - MSN
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13 - Business Wire
Barclays Lowers IQVIA Holdings (IQV) Price Target to $165 Amid Demand Concerns | IQV stock price - paginasiete.bo
IQVIA (IQV) Target Price Lowered by UBS, Rating Maintained | IQV Stock News - GuruFocus
IQVIA Holdings (IQV): Barclays Lowers Price Target to $165 | IQV Stock News - GuruFocus
Stephens Adjusts Price Target on IQVIA Holdings to $200 From $250, Maintains Overweight Rating - marketscreener.com
Citigroup Adjusts Price Target on IQVIA Holdings to $160 From $210, Maintains Neutral Rating - marketscreener.com
Baird Adjusts Price Target on IQVIA Holdings to $161 From $195, Maintains Neutral Rating - marketscreener.com
Barclays Adjusts Iqvia (IQV) Price Target Amid Demand Concerns | IQV Stock News - GuruFocus
IQVIA reports first-quarter 2025 results - IQVIA
IQVIA Holdings Inc (IQV) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
IQVIA Holdings Inc (IQV) Q1 2025 Earnings Call Highlights: Stron - GuruFocus
IQVIA: Q1 Earnings Snapshot - CTPost
Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight - GuruFocus
IQVIA Holdings Reports Strong Q1 2025 Results - TipRanks
IQVIA (IQV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
IQVIA Q1 2025 Earnings Call Transcript - MarketBeat
IQVIA Holdings’ Earnings Call: Mixed Sentiment Amid Growth - TipRanks
IQVIA Q1 2025 slides: Revenue up 2.5%, adjusted EPS beats expectations - Investing.com Nigeria
IQVIA HOLDINGS INC. SEC 10-Q Report - TradingView
IQVIA Holdings (NYSE:IQV) Reports US$3,829 Million Sales Q1 2025; Raises Full-Year Revenue Guidance - Yahoo Finance
Questex’s Fierce Pharma Announces the 2025 Fierce Pharma Marketing Awards Call for Submissions - GlobeNewswire Inc.
IQVIA Earnings & Revenues Beat Estimates in Q1, Increase Y/Y - TradingView
IQVIA Holdings Inc. Reports Impressive Q1 CY2025 Financial ResultsNews and Statistics - IndexBox
IQVIA Beats Q1 Earnings Expectations Despite Sector Uncertainty, Company Navigating Market Conditions 'Effectively' Says CEO - Benzinga
Datadog, Marriott, IQVIA - TradingView
IQVIA Ups Revenue Forecast After Exceeding Profit Estimates - Finimize
IQV Boosts FY25 Revenue Forecast, Maintains Profit Projections | - GuruFocus
IQVIA (IQV) Exceeds Revenue Expectations with Strong Q1 Results - GuruFocus
IQVIA (NYSE:IQV) Beats Q1 Sales Targets, Full-Year Sales Guidance is Optimistic - Yahoo Finance
IQVIA Holdings Inc Reports Q1 2025 Earnings: Adjusted EPS of $2. - GuruFocus
IQVIA Holdings (IQV) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance
IQVIA Reports First-Quarter 2025 Results - BioSpace
IQVIA beats quarterly profit estimates on higher demand for research services - TradingView
IQV Boosts FY25 Revenue Forecast, Maintains Profit Projections | IQV Stock News - GuruFocus
IQVIA (IQV) Exceeds Revenue Expectations with Strong Q1 Results | IQV Stock News - GuruFocus
IQVIA Holdings' Q1 Adjusted Earnings, Revenue Rise; Raises 2025 Revenue Guidance - marketscreener.com
Earnings Flash (IQV) IQVIA Holdings Posts Q1 Revenue $3.83B, vs. FactSet Est of $3.77B - marketscreener.com
IQVIA to Announce First-Quarter 2025 Results on May 6, 2025 | IQ - GuruFocus
IQVIA (IQV) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
(IQV) Investment Analysis - news.stocktradersdaily.com
HSBC Downgrades IQVIA Holdings (BIT:1IQV) - Nasdaq
IQVIA (IQV) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - MSN
IQVIA Gears Up to Report Q1 Earnings: What's in Store for the Stock? - TradingView
IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
IQVIA Holdings Inc. (IQV): Among Billionaire Israel Englander’s Stock Picks with Huge Upside Potential - Insider Monkey
Billionaire Israel Englander’s 10 Stock Picks with Huge Upside Potential - Insider Monkey
Iqvia Holdings Inc Azioni (IQV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
8.66%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):